|Articles|May 15, 2004

Ophthalmic industry benefits from Pfizer acquisition, too

With Advanced Medical Optics' (AMO) acquisition of the Pfizer surgical sector, it bought a lot more than just products.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME